Aethlon Medical, Inc. (AEMD)
- Previous Close
1.5300 - Open
1.5100 - Bid --
- Ask --
- Day's Range
1.5100 - 1.5100 - 52 Week Range
1.3500 - 5.0000 - Volume
299 - Avg. Volume
8,396 - Market Cap (intraday)
3.97M - Beta (5Y Monthly) 1.94
- PE Ratio (TTM)
-- - EPS (TTM)
-5.0100 - Earnings Date Jun 26, 2024 - Jul 1, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
25.00
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.
www.aethlonmedical.comRecent News: AEMD
Performance Overview: AEMD
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AEMD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AEMD
Valuation Measures
Market Cap
3.98M
Enterprise Value
-2.99M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.40
Price/Book (mrq)
0.52
Enterprise Value/Revenue
-5.20
Enterprise Value/EBITDA
0.24
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-47.16%
Return on Equity (ttm)
-98.43%
Revenue (ttm)
574.25k
Net Income Avi to Common (ttm)
-12.25M
Diluted EPS (ttm)
-5.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
7.97M
Total Debt/Equity (mrq)
13.27%
Levered Free Cash Flow (ttm)
-5.87M